216 related articles for article (PubMed ID: 26598380)
1. Differential impact of high and low penetrance TNFRSF1A gene mutations on conventional and regulatory CD4+ T cell functions in TNFR1-associated periodic syndrome.
Pucino V; Lucherini OM; Perna F; Obici L; Merlini G; Cattalini M; La Torre F; Maggio MC; Lepore MT; Magnotti F; Galgani M; Galeazzi M; Marone G; De Rosa V; Talarico R; Cantarini L; Matarese G
J Leukoc Biol; 2016 May; 99(5):761-9. PubMed ID: 26598380
[TBL] [Abstract][Full Text] [Related]
2. Candidate genes in patients with autoinflammatory syndrome resembling tumor necrosis factor receptor-associated periodic syndrome without mutations in the TNFRSF1A gene.
Borghini S; Fiore M; Di Duca M; Caroli F; Finetti M; Santamaria G; Ferlito F; Bua F; Picco P; Obici L; Martini A; Gattorno M; Ceccherini I
J Rheumatol; 2011 Jul; 38(7):1378-84. PubMed ID: 21459945
[TBL] [Abstract][Full Text] [Related]
3. Differential cytokine secretion results from p65 and c-Rel NF-κB subunit signaling in peripheral blood mononuclear cells of TNF receptor-associated periodic syndrome patients.
Nedjai B; Hitman GA; Church LD; Minden K; Whiteford ML; McKee S; Stjernberg S; Pettersson T; Ranki A; Hawkins PN; Arkwright PD; McDermott MF; Turner MD
Cell Immunol; 2011; 268(2):55-9. PubMed ID: 21420073
[TBL] [Abstract][Full Text] [Related]
4. Identification of a new exon 2-skipped TNFR1 transcript: regulation by three functional polymorphisms of the TNFR-associated periodic syndrome (TRAPS) gene.
Rittore C; Sanchez E; Soler S; Barat-Houari M; Albers M; Obici L; McDermott MF; Touitou I; Grandemange S
Ann Rheum Dis; 2014 Jan; 73(1):290-7. PubMed ID: 23505244
[TBL] [Abstract][Full Text] [Related]
5. Analysis of NLRP3, MVK and TNFRSF1A variants in adult Greek patients with autoinflammatory symptoms.
Karagianni P; Nezos A; Ioakeim F; Tzioufas AG; Moutsopoulos HM
Clin Exp Rheumatol; 2018; 36(6 Suppl 115):86-89. PubMed ID: 30418111
[TBL] [Abstract][Full Text] [Related]
6. The expanding spectrum of low-penetrance TNFRSF1A gene variants in adults presenting with recurrent inflammatory attacks: clinical manifestations and long-term follow-up.
Cantarini L; Rigante D; Merlini G; Vitale A; Caso F; Lucherini OM; Sfriso P; Frediani B; Punzi L; Galeazzi M; Cimaz R; Obici L
Semin Arthritis Rheum; 2014 Jun; 43(6):818-23. PubMed ID: 24393624
[TBL] [Abstract][Full Text] [Related]
7. Autophagy contributes to inflammation in patients with TNFR-associated periodic syndrome (TRAPS).
Bachetti T; Chiesa S; Castagnola P; Bani D; Di Zanni E; Omenetti A; D'Osualdo A; Fraldi A; Ballabio A; Ravazzolo R; Martini A; Gattorno M; Ceccherini I
Ann Rheum Dis; 2013 Jun; 72(6):1044-52. PubMed ID: 23117241
[TBL] [Abstract][Full Text] [Related]
8. Functional analysis of a novel G87V TNFRSF1A mutation in patients with TNF receptor-associated periodic syndrome.
Tsuji S; Matsuzaki H; Iseki M; Nagasu A; Hirano H; Ishihara K; Ueda N; Honda Y; Horiuchi T; Nishikomori R; Morita Y; Mukai T
Clin Exp Immunol; 2019 Dec; 198(3):416-429. PubMed ID: 31429073
[TBL] [Abstract][Full Text] [Related]
9. Canakinumab for the treatment of TNF-receptor associated periodic syndrome.
La Torre F; Caparello MC; Cimaz R
Expert Rev Clin Immunol; 2017 Jun; 13(6):513-523. PubMed ID: 28454496
[TBL] [Abstract][Full Text] [Related]
10. A novel TNFRSF1A gene mutation in a patient with tumor necrosis factor receptor-associated periodic syndrome.
Khabazi A; Maralani M; Andalib S; Sakhinia E
Hematol Oncol Stem Cell Ther; 2018 Sep; 11(3):175-177. PubMed ID: 27793577
[TBL] [Abstract][Full Text] [Related]
11. Symptoms related to tumor necrosis factor receptor 1-associated periodic syndrome, multiple sclerosis, and severe rheumatoid arthritis in patients carrying the TNF receptor superfamily 1A D12E/p.Asp41Glu mutation.
Havla J; Lohse P; Gerdes LA; Hohlfeld R; Kümpfel T
J Rheumatol; 2013 Mar; 40(3):261-4. PubMed ID: 23322460
[TBL] [Abstract][Full Text] [Related]
12. Involvement of the same TNFR1 residue in mendelian and multifactorial inflammatory disorders.
Jéru I; Charmion S; Cochet E; Copin B; Duquesnoy P; Garcia MT; Le Borgne G; Cathebras P; Gaillat J; Karabina S; Dodé C; Lohse P; Hentgen V; Amselem S
PLoS One; 2013; 8(7):e69757. PubMed ID: 23894535
[TBL] [Abstract][Full Text] [Related]
13. The tumour necrosis factor receptor-associated periodic syndrome: current concepts.
Stojanov S; McDermott MF
Expert Rev Mol Med; 2005 Oct; 7(22):1-18. PubMed ID: 16216134
[TBL] [Abstract][Full Text] [Related]
14. Gene expression profile in TNF receptor-associated periodic syndrome reveals constitutively enhanced pathways and new players in the underlying inflammation.
Borghini S; Ferrera D; Prigione I; Fiore M; Ferraris C; Mirisola V; Amaro AA; Gueli I; Zammataro L; Gattorno M; Pfeffer U; Ceccherini I
Clin Exp Rheumatol; 2016; 34(6 Suppl 102):S121-S128. PubMed ID: 27310036
[TBL] [Abstract][Full Text] [Related]
15. TNFR1-d2 carrying the p.(Thr79Met) pathogenic variant is a potential novel actor of TNFα/TNFR1 signalling regulation in the pathophysiology of TRAPS.
Rittore C; Méchin D; Sanchez E; Marinèche L; Ea V; Soler S; Vereecke M; Mallavialle A; Richard E; Duroux-Richard I; Apparailly F; Touitou I; Grandemange S
Sci Rep; 2021 Feb; 11(1):4172. PubMed ID: 33603056
[TBL] [Abstract][Full Text] [Related]
16. Clinical and genetic features of Chinese adult patients with tumour necrosis factor receptor-associated periodic fever syndrome.
Zhao M; Luo Y; Wu D; Yang Y; Sun Y; Wang R; Shen M
Rheumatology (Oxford); 2020 Aug; 59(8):1969-1974. PubMed ID: 31774538
[TBL] [Abstract][Full Text] [Related]
17. Concerted action of wild-type and mutant TNF receptors enhances inflammation in TNF receptor 1-associated periodic fever syndrome.
Simon A; Park H; Maddipati R; Lobito AA; Bulua AC; Jackson AJ; Chae JJ; Ettinger R; de Koning HD; Cruz AC; Kastner DL; Komarow H; Siegel RM
Proc Natl Acad Sci U S A; 2010 May; 107(21):9801-6. PubMed ID: 20457915
[TBL] [Abstract][Full Text] [Related]
18. Different presentations in patients with tumor necrosis factor receptor-associated periodic syndrome mutations: report of two cases.
Celebi-Tayfur A; Bilginer Y; Finetti M; Gattorno M; Ozen S
Turk J Pediatr; 2013; 55(1):78-81. PubMed ID: 23692837
[TBL] [Abstract][Full Text] [Related]
19. Delights and let-downs in the management of tumor necrosis factor receptor-associated periodic syndrome: the canakinumab experience in a patient with a high-penetrance T50M TNFRSF1A variant.
Cantarini L; Lopalco G; Vitale A; Caso F; Lapadula G; Iannone F; Galeazzi M; Rigante D
Int J Rheum Dis; 2015 May; 18(4):473-5. PubMed ID: 25522898
[No Abstract] [Full Text] [Related]
20. The novel S59P mutation in the TNFRSF1A gene identified in an adult onset TNF receptor associated periodic syndrome (TRAPS) constitutively activates NF-κB pathway.
Greco E; Aita A; Galozzi P; Gava A; Sfriso P; Negm OH; Tighe P; Caso F; Navaglia F; Dazzo E; De Bortoli M; Rampazzo A; Obici L; Donadei S; Merlini G; Plebani M; Todd I; Basso D; Punzi L
Arthritis Res Ther; 2015 Apr; 17(1):93. PubMed ID: 25888769
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
